Glaxosmithkline Pakistan LimitedPSX: GLAXO

Notice of Board of Directors Meeting (Q3-2025)

· Issued by GlaxoSmithKline Pakistan Limited


16th October 2025

The General Manager

Pakistan Stocl‹ Exchange Limited Stock Exchange Building

Stock Exchange Road Karachi 74000

Dear Sir,

Subject: Board of Directors Meeting

GlaxoSmithKline Pakistan Limited 35-Dockyard Road, West Wharf, Karachi - 74000, Pakistan

T +92 21 111 475 725

Please be informed that the meeting of the Board of Directors of GlaxoSmithKline Pakistan Limited, will be held on Friday, October 24, 2025 at 12:00 pm at Karachi and via video link, for the consideration of the Financial Results of the Company for the quarter ended September 30, 2025.

The Company has declared a closed period from October 17th 2025 to October 24*h, 2025 (both days inclusive) as required under clause 5.6.4 of the Rule Book of Pakistan Stock Exchange.

Accordingly, no Director, Chief Executive Officer, Chief Financial Officer, Company Secretary, Substantial Shareholder, and any other Executives of the Company or their spouses shall directly/indirectly deal in the shares of the Company in any manner during the closed period.

You may please inform the TRE Certificate Holders of the Exchange accordingly. Thanl‹ing you,

For GlaxoSmithKline Pakistan Limited

Hina Mir



Company Secretary

CC: Central Depository Company of Pakistan Limited CDC House, 99-B, Block B

S.M.C.H.S, Shahrah-e-Faisal, Karachi, 74000

Earlier from Glaxosmithkline Pakistan

All Glaxosmithkline Pakistan news releases